This suggests that targeting the ADGRA3-Gs-PKA-CREB signaling pathway could potentially be a therapeutic approach for obesity and related metabolic disorders. This evidence concerns the gene ADGRA3 and obesity due to melanocortin 4 receptor deficiency.